Twist Bioscience Corp

CRISPR Therapeutics

Recursion Pharmaceuticals

CareDx

Adaptive Biotechnologies

Veracyte

Ionis Pharma

Nurix Therapeutics, Inc

Intellia Therapeutics

10X Genomics

ARK Genomic Revolution Multi-Sector ETF

ARKG is an actively managed fund that targets companies involved in the genomics industry.

Patients may suffer from the same ailments, but no two medical problems are exactly alike. That much is confirmed by genetic code, indicating the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is an avenue for investors looking to tap into increasing levels of personalized care in cancer treatment.

How ARKG's Genomics Will Personalize Cancer Treatment

ARK Fintech Innovation ETF

ARK Innovation ETF

ARK Industrial Innovation ETF

ARK Web x.0 ETF

ARK Invest has been the talk of Wall Street over the last couple of years, outperforming the market and solidifying its place among the big players in the investments world.

Cathie Wood's ARK Invest Buys and Sells 3/30

Cathie Wood's ARK Invest Buys and Sells 3/29

Cathie Wood's Ark Investment Management sends out an email every night listing the stocks that were bought or sold by the firm's ETFs that day. In recent months, the emails have known to cause certain stocks to see a spike in the after-hours session.

Alibaba, Amazon, Palantir, Google, Takeda, Unity — What Cathie Wood's Ark Bought And Sold On Thursday

Cathie Wood's ARK Invest Buys and Sells 3/25

Thematic ETFs saw net inflows of $42.6 billion in the first two months of this year, more than three times the $13.3 billion garnered in the same period last year.

Thematic Investing on the Rise: ARK ETFs Leading the Pack

Cathie Wood's ARK Invest Buys and Sells 3/24

Cathie Wood's ARK Invest Buys and Sells 3/23

Cathie Wood's ARK Invest Buys and Sells 3/19

Cathie Wood's ARK Invest Buys and Sells 3/18

Cathie Wood's ARK Invest Buys and Sells 3/17

Cathie Wood's ARK Invest Buys and Sells 3/16

iShares MSCI USA Momentum Factor ETF

Invesco S&P 500 Equal Weight ETF

Invesco S&P 500 Low Volatility ETF

What active ARK ETFs and smart beta have in common.

Why Avoiding Alpha A Good ETF Play

The DNA sequencing and genomics markets move fast. Good news for investors: the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is up to speed.

Synthetic Biology: What It Is and Why ‘ARKG' Is So Levered to It

Cathie Wood's ARK Invest Buys and Sells 3/15

Cathie Wood's ARK Invest Buys and Sells 3/12

Cathie Wood's ARK Invest Buys and Sells 3/10

Cathie Wood's ARK Invest Buys and Sells 3/9

Block

Teladoc

Tesla

The active ETF manager got a big break from Wall Street.

Why Cathie Wood's 3 Stock Favorites Got a Big Boost From the Market Tuesday

Cathie Wood's ARK Invest Buys and Sells 3/8

ARK Israel Innovative Technology ETF

The 3D Printing ETF

Three of seven ARK ETFs are down on a year-to-date basis, but every fund has registered net inflows for the year.

ARK ETFs Wipe Out 2021 Gains As Investors Hold Tight

ARKG tends to have fairly high ownership of the market cap of its holdings. ARKG's most recent buys don't have evidence of consistent herd behavior in the following trading day.

ARKG: Evaluating High Ownership And Herd Behavior Risk Factors

Cathie Wood's ARK Invest Buys and Sells 3/5

Cathie Wood's ARK Invest Buys and Sells 3/4

Compugen

Stratasys

Catherine Wood has plunged deeper into illiquid stocks in an effort to prop up faltering positions

ARK Invest: Illiquid Positions Threaten to Drown Bubbly ETFs

News for ARK Genomic Revolution Multi-Sector ETF ETF (ARKG)